[PDF] Top 20 Autologous stem cell transplantation for the treatment of pediatric solid tumors in Brazil

Autologous stem cell transplantation for the treatment of pediatric solid tumors in Brazil

... transplant. In summary, this regimen is well tolerated, without increased TRM or GVHD, and supports engraftment with varied stem cell sources despite risk factors for graft ...Lymphopenia in ... See full document

2

Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients

... used in this study: the Short Form 36 Health Survey (SF- 36) 2 and the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire- C30 ...3 ... See full document

5

Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosis.

... variety of primary or secondary disease processes, leading to glomerular sclerosis, renal fibrosis, and replacement of normal tissue structure by deposition of extracellular matrix, ultimately ... See full document

11

Rev. Bras. Hematol. Hemoter. vol.30 suppl.2

... with the same disease, have a poor prognosis and represent a discrete population in terms of disease biology, treatment-related complications, and overall ...85%-95% of older AML ... See full document

5

Rev. Bras. Hematol. Hemoter. vol.30 suppl.2

... provides the proof of principle that high dose immunosuppression coupled with autologous hematopoietic stem cell boosting can revert clinical type 1 DM in humans, it will hardly ... See full document

5

HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS

... age of 11 years (2-33), 10 male, were transplanted, 12/19 with measurable ...round cell tumor (DSRCT, 1), Wilms tumor (1), primitive neuroectodermal tumor (PNET, 2), synovial sarcoma (2), Ewing sarcoma (6, ... See full document

1

Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma: A Single Portuguese Center Experience

... group of patients (Group one) experienced good OS with this treatment ...no solid data comparing prospectively upfront Auto-SCT consolidation versus first line treatment with high ... See full document

5

Rev. Bras. Hematol. Hemoter. vol.31 suppl.2

... In the field of lymphoma, several treatment options have been successfully employed, including high dose chemotherapy, autologous stem cell transplantation and ... See full document

4

Rev. Bras. Hematol. Hemoter. vol.30 suppl.2

... increasing the dose of active drugs with shortening the time between cycles, resulting in dose-dense or dose-intense regimens; and 2) combining rituximab with ...particularly in ... See full document

5

HIGH DOSE CARBOPLATIN, ETOPOSIDE, MELPHALAN and AUTOLOGOUS HEMATOPOIETIC STEM CELL RESCUE WITH for the TREATMENT of RELAPSED PEDIATRIC GERM CELL TUMORS

... consideration of allogeneic HSCT for pediatric AML in CR1 utilizing matched sibling ...donors. The results using unrelated UCB stem cell sources suggest that young AML patients ... See full document

1

Rev. Bras. Hematol. Hemoter. vol.35 número2

... is the main treatment ...pancreatoblastoma in the pancreatic body and tail was submitted to preoperative ...and the tumor was resected with microscopic ...and autologous ... See full document

2

Rev. Bras. Hematol. Hemoter. vol.31 suppl.2

... Autologous stem cell transplantation (ASCT) has become the mainstay of the treatment of multiple myeloma (MM) in patients up to 65 years ...additional ... See full document

2

Transplante autólogo de células-tronco hematopoiéticas sem uso de hemocomponentes.

... Hematopoietic stem cell transplantation (HSCT) is standard therapy for the treatment of some hematological neoplasms and support with blood transfusions is considered essential ... See full document

4

Rev. Bras. Hematol. Hemoter. vol.37 número1

... stages of differentiation of the neoplastic clone may cause heterogeneity in ...MM. Cell surface antigens may be help- ful to determine the antigenic ...for the ... See full document

4

Rev. Bras. Hematol. Hemoter. vol.36 número1

... or the chi-squared test, as appropriate, while continuous variables were analyzed by the Student’s t-test in the case of two groups or one-way analysis of variance (ANOVA) for ... See full document

6

Rev. Bras. Hematol. Hemoter. vol.30 número4

... analysis of the prognostic factors showed significance for the type of leukemia according to the FAB classification, cytogenetics analysis, intensive consolidation and chronic GvHD ... See full document

2

Rev. Bras. Hematol. Hemoter. vol.34 número3

... trial, the Collaborative Trial in Relapsed Aggressive Lymphoma (CORAL) compared the rituximab, ifosfamide, carboplatin and etoposide (R-ICE) with rituximab, dexamethasone, cytarabine and cisplatinum ... See full document

4

Rev. Bras. Hematol. Hemoter. vol.31 suppl.2

... Using the overall survival (OS), disease free survival (DFS) and progression free survival (PFS), as well as associated toxicity, the purpose of this work was to evaluate the effectiveness ... See full document

6

Rev. LatinoAm. Enfermagem vol.20 número4

... that of heparin in preventing the aggregation of ibrin in the catheter ...prevent the formation or long term accumulation of ...on the fact that Lepirudin is ... See full document

9

Rev. Bras. Hematol. Hemoter. vol.31 suppl.2

... 2% of all non-Hodgkin's lymphomas (NHL). More than 80% of adult LBL, which is more common in adolescents and young patients, have a T- cell ... See full document

2